Literature DB >> 953561

Lymphocyte cytotoxicity for kidney cells in renal tubular acidosis of autoimmune liver disease.

A M Cochrane, D C Tsantoulos, A Moussouros, I G McFarlane, A L Eddleston, R Williams.   

Abstract

Sensitisation to a renal tubular antigen, Tamm-Horsfall glycoprotein, has been shown to be common in patients with renal tubular acidosis complicating autoimmune liver disease, and it has been suggested that this immune reaction, by damaging renal tubular cells, might be responsible for the acidification defect. The lymphocytes from 10 out of 13 patients with chronic active hepatitis or primary biliary cirrhosis and an associated renal tubular acidosis were shown to be cytotoxic for a kidney cell line known to secrete Tamm-Horsfall glycoprotein. The cytotoxic reaction was blocked by this antigen, but not by two other proteins, indicating that sensitisation to the renal glycoprotein was the likely cause of the target cell damage. Significant reduction in cytotoxicity after the addition of aggregated IgG suggested that the reaction was of the antibody-dependent cell-mediated type. These results, together with the finding of antigenic material in the surface membrane of liver cells that cross reacts immunologically with Tamm-Horsfall glycoprotein, provide an explanation for the association between chronic liver disease and renal tubular dysfunction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 953561      PMCID: PMC1687891          DOI: 10.1136/bmj.2.6030.276

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis.

Authors:  P L Golding; M Smith; R Williams
Journal:  Am J Med       Date:  1973-12       Impact factor: 4.965

2.  Cell-mediated immune responses in chronic liver diseases.

Authors:  M G Smith; P L Golding; A L Eddleston; C G Mitchell; A Kemp; R Williams
Journal:  Br Med J       Date:  1972-02-26

3.  An in vitro assay for cellular hypersensitivity in man.

Authors:  R E Rocklin; O L Meyers; J R David
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

4.  Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors:  A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

5.  Cell-mediated immune response in primary biliary cirrhosis to a protein fraction from human bile.

Authors:  A L Eddleston; I G McFarlane; C G Mitchell; W D Reed; R Williams
Journal:  Br Med J       Date:  1973-11-03

6.  Tamm-Horsfall urinary glycoprotein. The chemical composition.

Authors:  A P Fletcher; A Neuberger; W A Ratcliffe
Journal:  Biochem J       Date:  1970-11       Impact factor: 3.857

  6 in total
  5 in total

1.  Hepatocyte plasma membrane antigens. II. Characterization of liver-specific membrane lipoprotein (LP-1) and Tamm-Horsfall glycoprotein (THGP) like antigens (hepatic THGP) on the plasma membrane of Chang liver cell.

Authors:  K Sakaguchi; N Koide; H Kondow; T Tanabe; M Jitoku; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1983-08

2.  The presence in serum of proteins which are immunologically cross-reactive with Tamm-Horsfall glycoprotein.

Authors:  K L Lynn; R D Marshall
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

3.  Stimulation of human peripheral blood lymphocytes by Tamm-Horsfall urinary glycoprotein.

Authors:  J S Hunt; A R McGiven
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

4.  Hepatocyte plasma membrane antigens. I. Determination of antibodies bound to the hepatocyte plasma membrane by 125I-protein A binding assay.

Authors:  K Sakaguchi
Journal:  Gastroenterol Jpn       Date:  1983-08

5.  Distal Renal Tubular Acidosis Associated with Autoimmune Diseases: Reports of 3 Cases and Review of Mechanisms.

Authors:  Marcelo Augusto Duarte Silveira; Antônio Carlos Seguro; Samirah Abreu Gomes; Maria Helena Vaisbich; Lúcia Andrade
Journal:  Am J Case Rep       Date:  2022-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.